Charles J Casamento insider trades: Relmada Therapeutics (RLMD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Charles reports to the SEC
and 7 more companies
Open-market buys and sales
27 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 9, 2024 | RLMD | ↑ Buy | 13,000 | $2.56 | $33K | Direct | Sep 11, 2024 (2d) |
| Sep 15, 2023 | FWBI | ↓ Sell | 10 | $0.43 | $4 | Direct | Sep 18, 2023 (3d) |
| Aug 31, 2023 | FWBI | ↓ Sell | 6,053 | $0.30 | $2K | Direct | Sep 5, 2023 (5d) |
| Apr 1, 2022 | RLMD | ↓ Sell | 19,800 | $29.00 | $574K | Direct | Apr 5, 2022 (4d) |
| Sep 22, 2021 | RLMD | ↓ Sell | 6,600 | $29.00 | $191K | Direct | Sep 24, 2021 (2d) |
| Jul 15, 2021 | RLMD | ↓ Sell | 3,300 | $31.54 | $104K | Direct | Jul 16, 2021 (1d) |
| Jun 1, 2021 | RLMD | ↓ Sell | 3,000 | $33.34 | $100K | Direct | Jun 2, 2021 (1d) |
| May 3, 2021 | RLMD | ↓ Sell | 3,000 | $38.22 | $115K | Direct | May 5, 2021 (2d) |
| Apr 1, 2021 | RLMD | ↓ Sell | 3,000 | $35.43 | $106K | Direct | Apr 5, 2021 (4d) |
| Mar 1, 2021 | RLMD | ↓ Sell | 3,000 | $33.87 | $102K | Direct | Mar 2, 2021 (1d) |
| Feb 1, 2021 | RLMD | ↓ Sell | 3,000 | $33.63 | $101K | Direct | Feb 2, 2021 (1d) |
| Jan 4, 2021 | RLMD | ↓ Sell10b5-1 | 3,000 | $32.11 | $96K | Direct | Jan 5, 2021 (1d) |
| Dec 1, 2020 | RLMD | ↓ Sell10b5-1 | 3,000 | $35.74 | $107K | Direct | Dec 2, 2020 (1d) |
| Nov 2, 2020 | RLMD | ↓ Sell10b5-1 | 3,000 | $30.29 | $91K | Direct | Nov 3, 2020 (1d) |
| Oct 1, 2020 | RLMD | ↓ Sell10b5-1 | 3,000 | $37.99 | $114K | Direct | Oct 2, 2020 (1d) |
| Sep 1, 2020 | RLMD | ↓ Sell10b5-1 | 3,000 | $34.74 | $104K | Direct | Sep 2, 2020 (1d) |
| Aug 3, 2020 | RLMD | ↓ Sell10b5-1 | 3,000 | $35.74 | $107K | Direct | Aug 4, 2020 (1d) |
| Jul 1, 2020 | RLMD | ↓ Sell10b5-1 | 3,000 | $43.89 | $132K | Direct | Jul 2, 2020 (1d) |
| Aug 9, 2019 | ETON | ↑ Buy | 3,500 | $6.11 | $21K | Direct | Aug 12, 2019 (3d) |
| Dec 28, 2018 | AZRX | ↑ Buy | 9,000 | $1.41 | $13K | Direct | Jan 2, 2019 (5d) |
| Nov 15, 2018 | ETON | ↑ Buy | 5,000 | $6.00 | $30K | Direct | Nov 15, 2018 (0d) |
| Dec 14, 2015 | RLMD | ↑ Buy | 4,200 | $2.97 | $12K | Direct | Dec 16, 2015 (2d) |
| May 3, 2013 | ASTX | ↓ Sell | 71,000 | $5.87 | $417K | Direct | May 7, 2013 (4d) |
| Mar 13, 2013 | ASTX | ↓ Sell | 14,000 | $4.27 | $60K | Direct | Mar 15, 2013 (2d) |
| Aug 20, 2012 | VVUS | ↓ Sell | 8,000 | $20.63 | $165K | Direct | Aug 21, 2012 (1d) |
| Mar 12, 2012 | VVUS | ↓ Sell | 37,000 | $20.14 | $745K | Direct | Mar 13, 2012 (1d) |
| Nov 30, 2007 | COR | ↑ Buy | 15,000 | $0.50 | $8K | Direct | Nov 30, 2007 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RLMD insiders
Open-market trades in the last 12 months
About Charles J Casamento's insider trades
Charles J Casamento is a director at Relmada Therapeutics (RLMD). Since Nov 30, 2007, Charles has reported 6 open-market purchases worth $117K and 21 sales worth $3.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
7 sales (21% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (98 filings), option exercises (16 filings), gifts (10 filings), shares withheld for taxes (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RLMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.